XML 21 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 01, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:        
Net income   $ 22,457    
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization   140,650    
Impairment expense      
Inventory write-down      
Contingent consideration adjustment      
Deferred income taxes   (31,244)    
Provision for doubtful accounts   4,444 $ 1,700 $ 8,100
Equity (earnings) loss from unconsolidated affiliate   83 5,700 (500)
(Gain) loss on disposal of assets   (31,463)    
Share-based compensation expense   23,437    
Amortization of deferred financing costs   608    
Accretion of original issue discount      
Reorganization items, net      
Changes in operating assets and liabilities:        
Accounts receivable   (203,101)    
Inventories   (26,072)    
Prepaid expenses and other current assets   16,013    
Accounts payable   41,801    
Payroll and related costs and accrued expenses   38,104    
Liabilities subject to compromise      
Income taxes receivable (payable)   1,714    
Other   2,663    
Net cash provided by (used in) operating activities   94    
Cash flows from investing activities:        
Purchases of and deposits on property, plant and equipment   (210,186)    
Proceeds from disposal of property, plant and equipment and non-core service lines   68,250    
Payments made for business acquisitions   (133,750)    
Other payments related to non-core service lines      
Net cash used in investing activities   (275,686)    
Cash flows from financing activities:        
Proceeds from revolving debt and term loans      
Payments on revolving debt and term loans      
Proceeds from DIP Facility      
Payments on DIP Facility      
Payments of capital lease obligations      
Financing costs   (1,739)    
Proceeds from issuance of common stock, net of offering costs   215,920    
Registration costs associated with issuance of common stock      
Employee tax withholding on restricted stock vesting   (3,842)    
Excess tax benefit (expense) from share-based compensation      
Net cash provided by financing activities   210,339    
Effect of exchange rate on cash   (2,102)    
Net increase (decrease) in cash and cash equivalents   (67,355)    
Cash and cash equivalents, beginning of year $ 181,242 181,242    
Cash and cash equivalents, end of year   113,887 181,242  
Predecessor [Member]        
Cash flows from operating activities:        
Net income 298,582   (944,289) (872,542)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization   217,440 276,353
Impairment expense   436,395 791,807
Inventory write-down   35,350 31,109
Contingent consideration adjustment   (4,700) (11,147)
Deferred income taxes (4,613)   (129,533) (273,144)
Provision for doubtful accounts   1,735 8,071
Equity (earnings) loss from unconsolidated affiliate   5,663 (500)
(Gain) loss on disposal of assets   3,075 (544)
Share-based compensation expense   17,740 18,549
Amortization of deferred financing costs   48,310 10,926
Accretion of original issue discount   52,414 6,187
Reorganization items, net (315,626)   30,611
Changes in operating assets and liabilities:        
Accounts receivable   137,075 278,150
Inventories   4,244 21,123
Prepaid expenses and other current assets   24,447 (26,821)
Accounts payable   (75,016) (168,607)
Payroll and related costs and accrued expenses (1,436)   35,028 17,400
Liabilities subject to compromise (33,000)  
Income taxes receivable (payable)   3,604 (108)
Other   (6,965) (3,257)
Net cash provided by (used in) operating activities (56,093)   (107,372) 103,005
Cash flows from investing activities:        
Purchases of and deposits on property, plant and equipment   (57,909) (166,321)
Proceeds from disposal of property, plant and equipment and non-core service lines   32,809 4,468
Payments made for business acquisitions   (663,303)
Other payments related to non-core service lines   (1,827)
Net cash used in investing activities   (26,927) (825,156)
Cash flows from financing activities:        
Proceeds from revolving debt and term loans   174,000 1,339,400
Payments on revolving debt and term loans   (13,250) (539,950)
Proceeds from DIP Facility   23,000
Payments on DIP Facility (25,000)  
Payments of capital lease obligations   (2,388) (3,874)
Financing costs (2,248)   (1,009) (55,450)
Proceeds from issuance of common stock, net of offering costs 200,000   453
Registration costs associated with issuance of common stock   (1,465)
Employee tax withholding on restricted stock vesting   (497) (2,621)
Excess tax benefit (expense) from share-based compensation   (5,592) (2,367)
Net cash provided by financing activities 172,752   174,264 734,126
Effect of exchange rate on cash   (1,282) 3,908
Net increase (decrease) in cash and cash equivalents 116,659   38,683 15,883
Cash and cash equivalents, beginning of year 64,583 $ 64,583 25,900 10,017
Cash and cash equivalents, end of year $ 181,242   $ 64,583 $ 25,900